Netherlands· NL-a57995e38ddf
Miconazolnitraat ratiopharm, hydrofiele creme 20 mg/g
A miconazole product containing miconazolnitraat, registered in Netherlands by ratiopharm GmbH. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Miconazole is registered in 12 of 19 countries.
Countries holding a registration under ATC D01AC02 (miconazole), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 6 of them publish a price we can compare per daily dose
Miconazole · ATC D01AC02
12 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of miconazole costs, country by country.
Normalised to the WHO defined daily dose (40 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Miconazole · price per daily dose (40 mg)
USD · FX 28 Sept 2026
- FR France$4.21
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- MICONAZOLNITRAAT
- Manufacturer
- ratiopharm GmbH
- Country
- Netherlands (NL)
- ATC code
- D01AC02
- ATC class
- Miconazole
- Defined daily dose
- 40 mg, T
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id20409
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for miconazole.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Miconazole · interactions on record
3 records
- 2 severe
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Miconazole in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United States2% MICONAZOLE NITRATE ANTIFUNGAL CreamGUANGZHOU YUSONG FINE CHEMICLS Co., Ltd
- PolandDaktarinMedezin Sp. z o.o.
- SpainDAKTARIN 20 MG/G CREMAJntl Consumer Health (Spain) S.L.
- NorwayDaktacortMcNeil Sweden AB
- United KingdomAcorvio 2% creamFerndale Pharmaceuticals Ltd
- GermanyCastellaniDr. K. Hollborn & Söhne Gmbh & Co. Kg
- FinlandDaktarinOrifarm Oy
- BelgiumAcneplus 20 mg/g - 50 mg/gLouis Widmer
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Daktarin
- Belgium · Daktarin, Gyno-Daktarin Vaginal
- Bulgaria · Дактарин
- Cyprus · Candiplas, Daktarin
- Germany · Castellani, Daktar
- Denmark · Brentan
- Spain · Daktarin, Fungisdin
- Finland · Daktarin
- France · Daktarin, Loramyc
- United Kingdom (Northern Ireland) · Daktarin, Daktarin Aktiv
- Greece · Daktarin, Daktarin Spray
- Croatia · Rojazol, Rojazolderm
- Ireland · Daktarin
- Italy · Daktarin, Daktarin Dermatologico
- Luxembourg · Daktarin, Gyno-Daktarin
- Latvia · Miconazole Tzf
- Malta · Daktarin, Miconazol Slavia
- Norway · Daktacort, Daktar
- Poland · Daktarin, Gyno-Femidazol
- Portugal · Daktarin
- Romania · Gynozol, Miconazol Slavia
- Sweden · Daktar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d0314b0c-83d3-4ef2-9e35-8b0ff453e01a GET /v1/drugs/d0314b0c-83d3-4ef2-9e35-8b0ff453e01a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Crème",
"route": "Cutaan gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h20409_smpc.pdf",
"strength": null,
"atc_label": "Miconazole",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg20409",
"excipients": [
"BENZOËZUUR (E 210)",
"ETHYLEENGLYCOLMONOPALMITOSTEARAAT",
"MACROGOLSTEARAAT, TYPE I",
"OLEOYL MACROGOLGLYCERIDES",
"PARAFFINE, VLOEIBAAR (E905)",
"WATER, GEZUIVERD"
],
"substances": [
"MICONAZOLNITRAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h20409.pdf",
"authorised_at": "1997/01/28",
"procedure_number": null,
"dispensing_status": "Uitsluitend apotheek of drogist",
"registration_number": "20409",
"additional_monitoring": "N"
}See everything about miconazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.